Recurrent Bacterial Vaginosis (BV)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent Bacterial Vaginosis (BV) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT06725888

Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.

This clinical trial is looking at how well and safely the vaginal administration of Vagitab-T works . Vagitab-T is already on the market in several countries in…

Romania30 participantsStarted 2025-03-31

Treatment: Vagitab -T vaginal tablets. Components: tyndallized probiotic L. plantarum HA-119, lactic acid, and xylo-oligosaccharides, lauryl glucoside, and macrogol 3350:

RecruitingNot Applicable

NCT05963711

The Genital Microbiome of Male Partners of Women with Recurrent BV Undergoing Vaginal Microbiome Transplantation

There is strong observational evidence that sexual activity plays a key role in Bacterial Vaginosis (BV) acquisition and recurrence. Microbiological data suppor…

Israel100 participantsStarted 2022-10-17

Treatment: chlorhexidine gluconate 4%

All recent trials (11 shown)

Not Yet RecruitingPhase 2

NCT07566754

MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH

The MOTIF@ FRESH trial will assess the safety and efficacy of "vaginal microbiome transplantation" (VMT). Healthy females will be enrolled to donate vaginal flu…

South Africa75 participantsStarted 2026-09

Treatment: Vaginal Microbiome Transplantation (VMT), oral metronidazole

Not Yet RecruitingPhase 2/3

NCT07527572

Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis

The vagina is a dynamic muscular organ whose health relies on a Lactobacillus-dominant microbiota that maintains low pH and protects against infections. Bacteri…

Location not specified160 participantsStarted 2026-04-01

Treatment: Lactobacillus gasseri KABP®064 10e9 CFU/capsule, Placebo (maltodextrin)

Recurrent Bacterial Vaginosis (BV)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.

The Genital Microbiome of Male Partners of Women with Recurrent BV Undergoing Vaginal Microbiome Transplantation

All recent trials (11 shown)

MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH

Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.

The Genital Microbiome of Male Partners of Women with Recurrent BV Undergoing Vaginal Microbiome Transplantation

All recent trials (11 shown)

MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH

Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis

Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients

Flourish HEC to Prevent Recurrence of BV

Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome

Randomized Controlled Trial of Treatment of Male Partners of Women With BV

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)